197 related articles for article (PubMed ID: 18079202)
1. Wnt pathway inhibitors are strongly down-regulated in pituitary tumors.
Elston MS; Gill AJ; Conaglen JV; Clarkson A; Shaw JM; Law AJ; Cook RJ; Little NS; Clifton-Bligh RJ; Robinson BG; McDonald KL
Endocrinology; 2008 Mar; 149(3):1235-42. PubMed ID: 18079202
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of the sFRP and WIF1 genes in invasive non-functioning pituitary adenomas.
Song W; Qian L; Jing G; Jie F; Xiaosong S; Chunhui L; Yangfang L; Guilin L; Gao H; Yazhuo Z
Mol Cell Endocrinol; 2018 Oct; 474():168-175. PubMed ID: 29555596
[TBL] [Abstract][Full Text] [Related]
3. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
[TBL] [Abstract][Full Text] [Related]
5. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
6. Wnt inhibitory factor-1 functions as a tumor suppressor through modulating Wnt/β-catenin signaling in neuroblastoma.
Zhang J; Zhou B; Liu Y; Chen K; Bao P; Wang Y; Wang J; Zhou Z; Sun X; Li Y
Cancer Lett; 2014 Jun; 348(1-2):12-9. PubMed ID: 24561119
[TBL] [Abstract][Full Text] [Related]
7. Promoter methylation of WNT inhibitory factor-1 and expression pattern of WNT/β-catenin pathway in human astrocytoma: pathologic and prognostic correlations.
Kim SA; Kwak J; Nam HY; Chun SM; Lee BW; Lee HJ; Khang SK; Kim SW
Mod Pathol; 2013 May; 26(5):626-39. PubMed ID: 23328978
[TBL] [Abstract][Full Text] [Related]
8. Association of TGF-β1 and WIF1 Expression with 36 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas: A High-Throughput Tissue Microarrays Immunohistochemical Study.
Zhu H; Yao X; Wu L; Li C; Bai J; Gao H; Ji H; Zhang Y
World Neurosurg; 2018 Nov; 119():e23-e31. PubMed ID: 29966778
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of Wnt pathway components in human salivary gland tumors.
Queimado L; Obeso D; Hatfield MD; Yang Y; Thompson DM; Reis AM
Arch Otolaryngol Head Neck Surg; 2008 Jan; 134(1):94-101. PubMed ID: 18209144
[TBL] [Abstract][Full Text] [Related]
10. Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells.
He B; Lee AY; Dadfarmay S; You L; Xu Z; Reguart N; Mazieres J; Mikami I; McCormick F; Jablons DM
Cancer Res; 2005 Feb; 65(3):743-8. PubMed ID: 15705870
[TBL] [Abstract][Full Text] [Related]
11. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; Martínez-Ansó E; Prieto J; Qian C
Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140
[TBL] [Abstract][Full Text] [Related]
12. WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells.
Tang Y; Simoneau AR; Liao WX; Yi G; Hope C; Liu F; Li S; Xie J; Holcombe RF; Jurnak FA; Mercola D; Hoang BH; Zi X
Mol Cancer Ther; 2009 Feb; 8(2):458-68. PubMed ID: 19174556
[TBL] [Abstract][Full Text] [Related]
13. Wnt inhibitory factor-1-mediated autophagy inhibits Wnt/β-catenin signaling by downregulating dishevelled-2 expression in non-small cell lung cancer cells.
Luo X; Ye S; Jiang Q; Gong Y; Yuan Y; Hu X; Su X; Zhu W
Int J Oncol; 2018 Aug; 53(2):904-914. PubMed ID: 29916529
[TBL] [Abstract][Full Text] [Related]
14. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
15. WIF1 can effectively co-regulate pro-apoptotic activity through the combination with DKK1.
Ko YB; Kim BR; Yoon K; Choi EK; Seo SH; Lee Y; Lee MA; Yang JB; Park MS; Rho SB
Cell Signal; 2014 Nov; 26(11):2562-72. PubMed ID: 25086206
[TBL] [Abstract][Full Text] [Related]
16. Wnt signaling pathway in invasive ductal carcinoma of the breast: relationship between beta-catenin, dishevelled and cyclin D1 expression.
Prasad CP; Gupta SD; Rath G; Ralhan R
Oncology; 2007; 73(1-2):112-7. PubMed ID: 18337623
[TBL] [Abstract][Full Text] [Related]
17. The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma.
Kongkham PN; Northcott PA; Croul SE; Smith CA; Taylor MD; Rutka JT
Oncogene; 2010 May; 29(20):3017-24. PubMed ID: 20208569
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of WIF1 and its inhibitory role in the tumor growth of endometrial adenocarcinoma.
Deng X; Hou C; Wang H; Liang T; Zhu L
Mol Med Rep; 2017 Nov; 16(5):7497-7503. PubMed ID: 28944908
[TBL] [Abstract][Full Text] [Related]
19. Wnt inhibitory factor 1 suppresses cancer stemness and induces cellular senescence.
Ramachandran I; Ganapathy V; Gillies E; Fonseca I; Sureban SM; Houchen CW; Reis A; Queimado L
Cell Death Dis; 2014 May; 5(5):e1246. PubMed ID: 24853424
[TBL] [Abstract][Full Text] [Related]
20. WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1.
Vassallo I; Zinn P; Lai M; Rajakannu P; Hamou MF; Hegi ME
Oncogene; 2016 Jan; 35(1):12-21. PubMed ID: 25772239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
